On May 8, 2020, BioReference Laboratories, an OPKO Health company, announced the launch of COVID-19 antibody screening available to New York City residents in partnership with New York City Health and Hospital Corporation (NYC Health + Hospitals). Testing will initially be performed for 140,000 residents at five locations across all five boroughs, with more testing sites to open. Test results will be available through BioReference’s Patient Portal, accessible by smartphone, tablet, desktop or traditional US Mail and become available within 1-3 days, on average.